A new large, international study finds that the immunosuppressant drug mycophenolate mofetil is superior to azathioprine, an older immunosuppressant, as a maintenance therapy for lupus nephritis…
More: continued here
Filed under: Lupus on November 17th, 2011 | No Comments »
Newly published research shows that more patients with end-stage renal disease (ESRD) caused by lupus nephritis choose hemodialysis as their initial kidney replacement therapy over peritoneal dialysis and preemptive kidney transplantation…
More: continued here
Filed under: Lupus on November 8th, 2011 | No Comments »
The first step towards successful medical care is to see a physician, but for some patients this isn’t as simple or easy as it may sound. A study presented at the 2011 Annual Scientific Meeting of the American College of Rheumatology in Chicago, finds that many lupus patients with low socioeconomic status are unable to […]
Filed under: Lupus on November 7th, 2011 | No Comments »
CBio Limited have announced the publication of their animal trial on the advanced access site of the Oxford Journals publication, Nephrology Dialysis Transplantation. The research is titled - “Recombinant chaperonin10 (Xtoll) suppresses cutaneous lupus and lupus nephritis in MRL-(Fas)lpr mice.” According to results of the study, using XToll to treat mice completely prevented cutaneous […]
Filed under: Lupus on November 6th, 2011 | No Comments »
The current classification system for kidney complications in patients with lupus is too detailed, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results should make it easier for physicians to classify and treat kidney problems in patients with the disease…
More: continued here
Filed under: Lupus on October 30th, 2011 | No Comments »
According to the American College of Rheumatology (ACR) 322,000 adult Americans are affected by systemic lupus erythematosus (SLE) with approximately 5,000 to 10,000 children in the U.S. affected by lupus (Lehman 1996), although exact figures for pediatric SLE cases remain difficult to establish…
More: continued here
Filed under: Lupus on October 30th, 2011 | No Comments »
Researchers at Albert Einstein College of Medicine of Yeshiva University have shown that close supervision by rheumatologists and the use of immunosuppressant drugs improve the survival of lupus patients with end-stage kidney disease a finding that could reverse long-standing clinical practice. Their study appeared in the September 1 online edition of the Journal of Rheumatology. […]
Filed under: Lupus on September 21st, 2011 | No Comments »
Researchers have just found that vitamin D levels among systemic lupus erythematosis (SLE) patients directly relates to the severity of the disease and the development of the infection. The study found that people with low levels of vitamin D are more prone to develop SLE than those with higher levels…
More: continued here
Filed under: Lupus on August 5th, 2011 | No Comments »
The first treatment developed for lupus in over 50 years has finally been approved by the European Union this week. The watchdog, European Medicines Agency, has backed the injectable drug that will cost Europeans $23,000 USD a year. Already approved in the United States in March 2011, the drug costs Americans $35,000 USD […]
Filed under: Lupus on July 17th, 2011 | No Comments »
Lupus has a profoundly negative effect on the working lives of sufferers’, found a survey of over 2,000 lupus patients presented at the Annual Meeting of the European League Against Rheumatism (EULAR) in London, May 25-28. “We’ve shown just how debilitating lupus can be in terms of the number of patients […]
Filed under: Lupus on May 30th, 2011 | No Comments »